One year after launch of real-world CLARIFY study, preliminary data from the first 1,000 enrolled patients will be presented ...

Oral presentation to highlight initial data from ongoing pivotal Phase 2 study of rezatapopt, a first-in-class precision oncology investigational therapy, in patients with advanced solid tumors ...